                               SEQUENCE LISTING

<110> FIGENE, LLC
 
<120> THERAPEUTIC USES OF GENE EDITED FIBROBLASTS

<130> AMTK.P0031WO-1001100467

<140> PCT/US2019/066575
<141> 2019-12-16

<150> 62/780,289
<151> 2018-12-16

<160> 5     

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
gaaaatgttt cctgactcag                                                   20


<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
ccccggacga tattgaacaa                                                   20


<210> 3
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
tcctacacaa tgcgttgcc                                                    19


<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
tggcacactg tgagctgcct                                                   20


<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
gcccctagaa ggtggctacc                                                   20


